Carolinas Wealth Consulting’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-42
| Closed | -$26.6K | – | 735 |
|
|
2025
Q1 | $26.6K | Buy |
42
+1
| +2% | +$634 | 0.01% | 423 |
|
|
2024
Q4 | $29.2K | Sell |
41
-8
| -16% | -$5.7K | 0.01% | 427 |
|
|
2024
Q3 | $51.5K | Buy |
49
+2
| +4% | +$2.1K | 0.01% | 361 |
|
|
2024
Q2 | $49.4K | Sell |
47
-2
| -4% | -$2.1K | 0.01% | 368 |
|
|
2024
Q1 | $47.2K | Buy |
49
+1
| +2% | +$962 | 0.01% | 386 |
|
|
2023
Q4 | $42.2K | Hold |
48
| – | – | 0.01% | 360 |
|
|
2023
Q3 | $37.4K | Sell |
48
-4
| -8% | -$3.12K | 0.01% | 348 |
|
|
2023
Q2 | $37.4K | Sell |
52
-16
| -24% | -$11.5K | 0.01% | 393 |
|
|
2023
Q1 | $55.9K | Sell |
68
-10
| -13% | -$8.22K | 0.01% | 338 |
|
|
2022
Q4 | $56.3K | Hold |
78
| – | – | 0.01% | 331 |
|
|
2022
Q3 | $54K | Buy |
78
+22
| +39% | +$15.2K | 0.01% | 316 |
|
|
2022
Q2 | $33K | Hold |
56
| – | – | 0.01% | 381 |
|
|
2022
Q1 | $39K | Sell |
56
-1
| -2% | -$696 | 0.01% | 383 |
|
|
2021
Q4 | $36K | Hold |
57
| – | – | 0.01% | 411 |
|
|
2021
Q3 | $34K | Buy |
57
+1
| +2% | +$596 | 0.01% | 396 |
|
|
2021
Q2 | $31K | Sell |
56
-1
| -2% | -$554 | 0.01% | 429 |
|
|
2021
Q1 | $27K | Hold |
57
| – | – | 0.01% | 460 |
|
|
2020
Q4 | $28K | Hold |
57
| – | – | 0.01% | 425 |
|
|
2020
Q3 | $32K | Buy |
57
+22
| +63% | +$12.4K | 0.01% | 345 |
|
|
2020
Q2 | $22K | Buy |
+35
| New | +$22K | 0.01% | 279 |
|